Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hobbs

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung CancerYifan Wang, Jayanthi Gudikote, Uma Giri, et al.
The Lancet. Respiratory Medicine|October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trialT M Maher, J G Goldin, J Hood, et al.
Annals of Surgical Oncology|January 4, 2021
Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-AnalysisChirag Shah, Xuefei Jia, Brian P Hobbs, et al.
NMR in Biomedicine|October 10, 2015
Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot studyYao Ding, John D Hazle, Abdallah S R Mohamed, et al.
Nature Genetics|July 14, 2015
Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytesRyan P Hobbs, Daryle J DePianto, Justin T Jacob, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2026
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLCPeter S N van Rossum, Pim J J Damen, Francesco Cortiula, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2017
Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapyYutaka Shiraishi, Penny Fang, Cai Xu, et al.
Med (New York, N.Y.)|May 26, 2021
Increased Incidence of Venous Thromboembolism with Cancer ImmunotherapyJoanna Roopkumar, Shadi Swaidani, Ann S Kim, et al.
The Lancet. Oncology|August 21, 2019
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 studyMoshe C Ornstein, Sumanta K Pal, Laura S Wood, et al.
The Laryngoscope|July 22, 2016
Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinomaRyan P Goepfert, Jan S Lewin, Martha P Barrow, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung CancerYifan Wang, Jayanthi Gudikote, Uma Giri, et al.
The Lancet. Respiratory Medicine|October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trialT M Maher, J G Goldin, J Hood, et al.
Annals of Surgical Oncology|January 4, 2021
Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-AnalysisChirag Shah, Xuefei Jia, Brian P Hobbs, et al.
NMR in Biomedicine|October 10, 2015
Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot studyYao Ding, John D Hazle, Abdallah S R Mohamed, et al.
Nature Genetics|July 14, 2015
Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytesRyan P Hobbs, Daryle J DePianto, Justin T Jacob, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2026
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLCPeter S N van Rossum, Pim J J Damen, Francesco Cortiula, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2017
Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapyYutaka Shiraishi, Penny Fang, Cai Xu, et al.
Med (New York, N.Y.)|May 26, 2021
Increased Incidence of Venous Thromboembolism with Cancer ImmunotherapyJoanna Roopkumar, Shadi Swaidani, Ann S Kim, et al.
The Lancet. Oncology|August 21, 2019
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 studyMoshe C Ornstein, Sumanta K Pal, Laura S Wood, et al.
The Laryngoscope|July 22, 2016
Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinomaRyan P Goepfert, Jan S Lewin, Martha P Barrow, et al.
Pageof 22